Why Illumina Rose 18.7% in August
Shares of Illumina (NASDAQ: ILMN), a leading manufacturer of genetic testing equipment, rose 18.7% in August, according to data from S&P Global Market Intelligence. Investors can thank solid second-quarter results and bullish guidance for the big jump.
Here's a review of the key takeaways from the company's impressive second quarter:
Given the estimate topping results and bullish revenue guidance, it isn't hard to figure out why shareholders had a great month.
Source: Fool.com
Illumina Inc. Stock
€115.42
1.850%
With 27 Buy predictions and 4 Sell predictions Illumina Inc. is one of the favorites of our community.
With a target price of 162 € there is a positive potential of 40.36% for Illumina Inc. compared to the current price of 115.42 €.
